Table of Contents

2019-2024 Global Gene Therapy in Oncology Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size 2014-2024
2.1.2 Gene Therapy in Oncology Market Size CAGR by Region
2.2 Gene Therapy in Oncology Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy in Oncology Market Size by Type
2.3.1 Global Gene Therapy in Oncology Market Size Market Share by Type (2014-2019)
2.3.2 Global Gene Therapy in Oncology Market Size Growth Rate by Type (2014-2019)
2.4 Gene Therapy in Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Gene Therapy in Oncology Market Size by Application
2.5.1 Global Gene Therapy in Oncology Market Size Market Share by Application (2014-2019)
2.5.2 Global Gene Therapy in Oncology Market Size Growth Rate by Application (2014-2019)

3 Global Gene Therapy in Oncology by Players
3.1 Global Gene Therapy in Oncology Market Size Market Share by Players
3.1.1 Global Gene Therapy in Oncology Market Size by Players (2017-2019)
3.1.2 Global Gene Therapy in Oncology Market Size Market Share by Players (2017-2019)
3.2 Global Gene Therapy in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy in Oncology by Regions
4.1 Gene Therapy in Oncology Market Size by Regions
4.2 Americas Gene Therapy in Oncology Market Size Growth
4.3 APAC Gene Therapy in Oncology Market Size Growth
4.4 Europe Gene Therapy in Oncology Market Size Growth
4.5 Middle East & Africa Gene Therapy in Oncology Market Size Growth

5 Americas
5.1 Americas Gene Therapy in Oncology Market Size by Countries
5.2 Americas Gene Therapy in Oncology Market Size by Type
5.3 Americas Gene Therapy in Oncology Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gene Therapy in Oncology Market Size by Countries
6.2 APAC Gene Therapy in Oncology Market Size by Type
6.3 APAC Gene Therapy in Oncology Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gene Therapy in Oncology by Countries
7.2 Europe Gene Therapy in Oncology Market Size by Type
7.3 Europe Gene Therapy in Oncology Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy in Oncology by Countries
8.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type
8.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Gene Therapy in Oncology Market Forecast
10.1 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)
10.2 Global Gene Therapy in Oncology Forecast by Regions
10.2.1 Global Gene Therapy in Oncology Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Gene Therapy in Oncology Forecast by Type
10.8 Global Gene Therapy in Oncology Forecast by Application

11 Key Players Analysis
11.1 Bristol-Myers Squibb
11.1.1 Company Details
11.1.2 Gene Therapy in Oncology Product Offered
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Bristol-Myers Squibb News
11.2 Cold Genesys
11.2.1 Company Details
11.2.2 Gene Therapy in Oncology Product Offered
11.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Cold Genesys News
11.3 Advantagene
11.3.1 Company Details
11.3.2 Gene Therapy in Oncology Product Offered
11.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Advantagene News
11.4 Amgen
11.4.1 Company Details
11.4.2 Gene Therapy in Oncology Product Offered
11.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Amgen News
11.5 AstraZeneca
11.5.1 Company Details
11.5.2 Gene Therapy in Oncology Product Offered
11.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 AstraZeneca News
11.6 Bio-Path Holdings
11.6.1 Company Details
11.6.2 Gene Therapy in Oncology Product Offered
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Bio-Path Holdings News
11.7 CRISPR Therapeutics
11.7.1 Company Details
11.7.2 Gene Therapy in Oncology Product Offered
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 CRISPR Therapeutics News
11.8 Editas Medicine
11.8.1 Company Details
11.8.2 Gene Therapy in Oncology Product Offered
11.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Editas Medicine News
11.9 Geron Corp
11.9.1 Company Details
11.9.2 Gene Therapy in Oncology Product Offered
11.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Geron Corp News
11.10 Idera Pharmaceuticals
11.10.1 Company Details
11.10.2 Gene Therapy in Oncology Product Offered
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Idera Pharmaceuticals News
11.11 Intellia Therapeutics
11.12 Johnson & Johnson
11.13 Marsala Biotech
11.14 Merck
11.15 Mologen AG
11.16 Oncolytics Biotech
11.17 Oncosec
11.18 Oncotelic
11.19 Shenzhen SiBiono GeneTech
11.20 Sillajen Biotherapeutics
11.21 Tocagen
11.22 UniQure
11.23 Ziopharm Oncology

12 Research Findings and Conclusion